Posts tagged Value Pickr
Screener.in: The destination for Intelligent Screening & Reporting in India (26-04-2024)
@R_Sawkar i checked; it does not work. There is no query like Bonus ratio in screener.
Priyank’s Portfolio (26-04-2024)
Could you share the company/partner you outsource it to?
Sandur Manganese (26-04-2024)
Acquisition: Sandur acquired Arjas Steel private ltd
07b53897-1fdc-4fbb-84af-0b4fa5b54d57.pdf (314.9 KB)
Screener.in: The destination for Intelligent Screening & Reporting in India (26-04-2024)
Thank you @R_Sawkar. I will check this out on screener.
Aptus Value Housing : Is valuation justified or just another HFC? (25-04-2024)
Hi, Harsh Bhai, how do you value Aptus Home First Finance for valuation? Which method do you prefer to use?
Aptus Value Housing : Is valuation justified or just another HFC? (25-04-2024)
The Malabar strategy for Aptus resembles a niche industry segment, buoyed by long-term secular growth and favorable tailwinds, with a nuanced consideration of interest rate impacts.
Within the affordable housing segment, there exists a notably limited penetration, offering a substantial runway for growth. Aptus stands out as a prominent player in this arena, benefiting from enduring tailwinds.
While interest rate tightening may have some impact on the housing finance segment, its effects are primarily limited to new flows and incremental borrowing. Effective management of assets and liabilities can mitigate these effects considerably. Although there is an undeniable impact, it remains relatively modest.
Moreover, there are additional levers at play, including operational expenditure management and asset quality control. Within the affordable housing sector, companies like Aptus possess sufficient resilience to navigate and absorb minimal interest rate hikes more adeptly than larger players with shorter asset durations.
Lincoln Pharma … the next mid-cap pharma in the making …? (25-04-2024)
Hi, Mridul. Lincon Pharma looks interesting to me. Could you please share the HDFC Sec report you mentioned in the comment? I’m unable to access the report. If you have it, kindly email it to me at adityashaw2604@gmail.com.
Priyank’s Portfolio (25-04-2024)
@ashutosh13 – have shared it above now
Priyank’s Portfolio (25-04-2024)
| Stock name | % of PF as per investment value |
|---|---|
| PPFAS🔒 | 22.8% |
| Triveni Engg | 7.6% |
| Ami Organics | 7.6% |
| Sansera Engineering🔒 | 7.6% |
| Exide Industries | 5.8% |
| Gokaldas (GOKEX) | 5.0% |
| Lupin | 4.2% |
| Shriram Piston | 3.8% |
| Astec Lifesciences | 3.8% |
| Sudarshan Chem | 3.8% |
| Craftsman | 3.8% |
| Shyam Metalics | 3.8% |
| TATA Motors – DVR | 3.8% |
| Old Bridge | 3.8% |
| L&T | 3.6% |
| NOCIL | 3.4% |
| Ion Exchange | 2.8% |
| Rolex Rings | 2.2% |
| Creative Newtech | 0.5% |
| SJS Enterprises | 0.3% |
Cash levels are considerably high. Will be looking to deploy over time
It’s been a while since I’ve reviewed my portfolio strategy. Here’s what’s influencing my thinking:
- Increased Commitments: Upcoming commitments limit the time I can dedicate to actively managing my portfolio. I’m looking for a more hands-off approach that aligns with my long-term goals. This means prioritizing stocks that require less frequent monitoring (compared to quarterly checks).
- Forensic Accounting Reliance: My current strategy relies on forensic accounting checks, which I outsource due to my knowledge limitations. This limits the potential investment watchlist.
Disclaimer: I am not a SEBI registered advisor or analyst. This is my personal view and not a recommendation. I am often wrong and do change my views without being able to inform anyone.